TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Neonc Technologies Holdings, Inc.
NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors

NeOnc Technologies revealed preclinical research demonstrating that ultrasound can enhance the therapeutic potency of NEO100 for treating primary and metastatic brain tumors, using an AI-driven 3D-bioprinted methodology.

Insights
F   positive

Committed $5 billion to EV investments, indicating continued market growth potential


NTHI   positive

The company presented promising research showing potential breakthrough in brain tumor treatment using AI and ultrasound technology, which could significantly expand their commercial and clinical opportunities